Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Approved for marketing × Recurrence × fludarabine × Clear all

Status

Completed 14 Unknown 12 Recruiting 11 Active not recruiting 11 Terminated 10 Not yet recruiting 4 Withdrawn 1 Enrolling by invitation 1 Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Lymphoma, Mantle-Cell 1

Interventions

ibrutinib 2 vorasidenib 1 talquetamab 1 pomalidomide 1 fludarabine 1 brexucabtagene autoleucel 1 axicabtagene ciloleucel 1 Cyclophosphamide 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04162756 2021-10-14

ZUMA-18

Gilead Sciences

Approved for marketing

Recurrence, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡